Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Alejandro Mejía Muñoz"'
Autor:
Miguel Octavio Pérez Navarro, Angela María Gaviria Núñez, Claudia María Cuervo Araque, Mónica María Figueroa, Alejandro Mejía Muñoz, Juan Aicardo Segura Caro
Publikováno v:
Public Health in Practice, Vol 5, Iss , Pp 100347- (2023)
Objectives: The aim of this study was to estimate the seroprevalence of anti-SARS-CoV-2 antibodies using the SARS-CoV-2 antibody test in a university population. Capillary blood and plasma samples were compared and correlated with symptomatology to e
Externí odkaz:
https://doaj.org/article/ecb20ceeef1044fe99590a13b4d3517d
Autor:
Juan Pablo Pérez Bedoya, Alejandro Mejía Muñoz, Noël Christopher Barengo, Paula Andrea Diaz Valencia
Publikováno v:
PLoS ONE, Vol 17, Iss 9 (2022)
Introduction Diabetes has been associated with an increased risk of complications in patients with COVID-19. Most studies do not differentiate between patients with type 1 and type 2 diabetes, which correspond to two pathophysiological distinct disea
Externí odkaz:
https://doaj.org/article/0516263b235c4260bdf6da6967028119
Autor:
Miguel Octavio Pérez Navarro, Angela María Gaviria Núñez, Claudia María Cuervo Araque, Mónica María Figueroa, Alejandro Mejía Muñoz, Juan Aicardo Segura Caro
Publikováno v:
Public health in practice (Oxford, England). 5
The aim of this study was to estimate the seroprevalence of anti-SARS-CoV-2 antibodies using the SARS-CoV-2 antibody test in a university population. Capillary blood and plasma samples were compared and correlated with symptomatology to establish rap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc898495bd3b42e1b74ae03f019b474d
https://pubmed.ncbi.nlm.nih.gov/36536854
https://pubmed.ncbi.nlm.nih.gov/36536854